Diagnostics

A new, non-invasive urine test from TOBY, Inc. has received FDA Breakthrough status, challenging blood-based rivals and promising a new era of accessible cancer detection.

Renaissance Pharma's Daretabart gains FDA support for high-risk neuroblastoma, accelerating its journey to patients and offering new hope against this rare disease.

Riding a wave of strong financial performance, Knowles Corp. prepares to outline its future in Medtech, Defense, and Industrial markets to investors.

With oral cancer on the rise, especially in younger adults, 49 surgical practices are offering free screenings. Here's why early detection is critical.

In a market demanding quality, Keiretsu Forum-MST presents 11 vetted startups at the ACA Summit, showcasing the future of medtech, AI, and energy.

Amid shrinking newsrooms and the rise of AI, a 55-year-old RI agency’s Gold Merit Award proves strategic specialization is key to earning credibility.

With youth melanoma a growing concern, a new curriculum gives teens free, classroom-ready tools to build lifelong sun safety habits and reduce their risk.

The insurer is offering at-home defibrillators and health tech, aiming to redefine its role from covering death to extending life. But what does it mean for you?

Caravel Autism Health's new clinic offers hope for families, highlighting Iowa's care shortages, recent insurance reforms, and a changing therapy landscape.

A landmark study reveals 100% tumor control with a personalized radiation therapy, offering profound new hope for patients with inoperable liver cancer.

Constellation Kidney Group's new RCM Intelligence uses AI to help dialysis providers navigate complex billing, reduce costly denials, and improve cash flow.

VITAL MedTech unveils a bold vertical integration strategy, leveraging its parent's semiconductor mastery to build imaging systems from raw materials to final scans.

Novarad showcases its FDA-cleared VisAR system, an AR platform promising sub-millimeter accuracy and faster workflows for interventional radiology.

A global pioneer and a top US expert join forces to bring a minimally invasive pain therapy to millions of Americans through a revolutionary outpatient model.

Landmark trial shows proton therapy boosts survival and cuts side effects, offering new hope as cancer rates climb in adults under 50.

At analytica 2026, Haier Biomedical unveiled its 'In Europe, For Europe' strategy, challenging market leaders with integrated solutions and local roots.

Five new clinical trials in Chicago repurpose existing drugs for PTSD, cancer, and more, offering a faster, cheaper path to treating unsolved diseases.

Healthcare M&A firm JW Advisory hires a key leader to expand West, aiming to professionalize practice sales in a rapidly consolidating market.

Inito's new InSight device uses Wi-Fi and AI to track four key hormones, promising unprecedented precision and a deeper understanding for those trying to conceive.

A new maternal blood test claims over 97% accuracy in predicting autism risk, offering hope for early intervention while igniting a fierce ethical debate.